Pacific Biosciences of California Inc PACB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore
-
PacBio Grants Equity Incentive Award to New Employee
-
PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific
-
Revio to Power Research in Male Infertility and Rare Disease at Münster University Hospital
-
PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
-
PacBio Announces Second Quarter 2024 Financial Results
-
Singapore’s National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia
-
PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm
Trading Information
- Previous Close Price
- $1.63
- Day Range
- $1.65–1.76
- 52-Week Range
- $1.16–10.65
- Bid/Ask
- $1.71 / $1.72
- Market Cap
- $468.75 Mil
- Volume/Avg
- 5.1 Mil / 9.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.42
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 796
- Website
- https://www.pacb.com
Comparables
Valuation
|
Metric
|
PACB
|
688468
|
GRAL
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 21.05 | — |
Price/Book Value | 0.95 | 2.05 | 0.15 |
Price/Sales | 2.42 | 6.16 | 3.69 |
Price/Cash Flow | — | 14.42 | — |
Price/Earnings
PACB
688468
GRAL
Financial Strength
|
Metric
|
PACB
|
688468
|
GRAL
|
|---|---|---|---|
Quick Ratio | 6.92 | 4.71 | 11.09 |
Current Ratio | 8.01 | 5.48 | 11.55 |
Interest Coverage | −27.85 | 111.54 | — |
Quick Ratio
PACB
688468
GRAL
Profitability
|
Metric
|
PACB
|
688468
|
GRAL
|
|---|---|---|---|
Return on Assets (Normalized) | −15.40% | 7.46% | −11.72% |
Return on Equity (Normalized) | −41.10% | 9.59% | −13.53% |
Return on Invested Capital (Normalized) | −16.00% | 7.98% | −13.47% |
Return on Assets
PACB
688468
GRAL
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Xpykcbws | Qfgwg | $196.0 Bil | |||
| Stryker Corp
SYK
| Khtzrlkps | Skqs | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Zhhdtbpv | Hfwpq | $124.5 Bil | |||
| Medtronic PLC
MDT
| Vhclrfk | Zrnsmhf | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Lmvhnsdyp | Crzjls | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Pct | Gtt | $30.2 Bil | |||
| DexCom Inc
DXCM
| Nkhddchgk | Nnqrl | $27.3 Bil | |||
| Steris PLC
STE
| Pwjydgxt | Lsrbp | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Wnmtypsft | Jdvd | $21.3 Bil | |||
| Insulet Corp
PODD
| Gmxdkdmv | Rvbkf | $16.1 Bil |
United States